Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...

Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...

The guideline recommendations advise universal use of hydroxychloroquine, minimizing steroids, and earlier introduction of ...

A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing ...

Clinigen, the global specialist pharmaceutical services Group, has appointed seasoned biopharma executive Paul Carter as Non-Executive Chair of its Board. This appointment strengthens the Board and ...

The strong financials and positive sentiment may have contributed to GlaxoSmithKline Pharmaceutical's stock reaching a new 52 ...

A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety and promising objective response rates in patients with few treatment choices ...

Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...

With GlaxoSmithKline Pharmaceuticals' shares trading at Rs 3187.00, the stock has shown a positive movement, driven by consistent financial performance and very bullish market sentiment.

Among patients who received four-drug consolidation therapy, 84% had measurable residual disease (MRD)-negative status before ...